Detalles de la búsqueda
1.
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Am J Respir Crit Care Med
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626354
2.
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
J Autoimmun
; 140: 103118, 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37826919
3.
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Clin Infect Dis
; 73(9): e2869-e2874, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32997739
4.
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients.
Cancer Immunol Immunother
; 70(2): 563-568, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32804246
5.
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors.
J Am Acad Dermatol
; 82(4): 854-861, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31449902
6.
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.
Cancer Immunol Immunother
; 67(1): 39-45, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28894934
7.
Short- and long-term effects of two emollients on itching and skin restoration in xerotic eczema.
Dermatol Ther
; 31(6): e12692, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30246910
8.
Readability Assessment of Patient Education Material Published by German-Speaking Associations of Urology.
Urol Int
; 100(1): 79-84, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29151111
9.
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Clin Infect Dis
; 73(9): 1746, 2021 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34550333
10.
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.
Cancers (Basel)
; 16(5)2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38473216
11.
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
Acta Neuropathol Commun
; 12(1): 70, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38698465
12.
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Med
; 4(2): 113-129.e7, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36693381
13.
Ocular Adverse Events Induced by Immune Checkpoint Inhibitors: A Comprehensive Pharmacovigilance Analysis.
Ocul Immunol Inflamm
; 30(1): 191-197, 2022 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749899
14.
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
J Cancer Res Clin Oncol
; 148(3): 647-656, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874490
15.
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
Sci Immunol
; 7(75): eabn9644, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054337
16.
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells.
Cell Metab
; 34(6): 857-873.e9, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35561674
17.
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
EMBO Mol Med
; 14(8): e15230, 2022 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781796
18.
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.
Oncoimmunology
; 10(1): 2006893, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858733
19.
Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors.
JAMA Netw Open
; 3(10): e2017675, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33095247
20.
Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors.
Eur J Cancer
; 107: 8-14, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30529903